Skip to main content

pharmacology

Meet the alpacas that are helping researchers who study autism, Alzheimer’s and cancer

Aug. 13, 2019—Written by Heidi Hall Alpacas aren’t the typical animals that drivers spot as they wind their way through rural Tennessee, but there’s a happy herd of them outside Waverly, where they eat the finest pellets, walk up and down a scenic hill and potentially save lives. They’re owned by a team of Vanderbilt University researchers...

Read more


Ancora announces major funding awards to support Vanderbilt drug discovery research

Nov. 26, 2018—Ancora Innovation, LLC, the new collaboration between Vanderbilt and Deerfield Management established earlier this year, has completed its inaugural proposal review process and announced two projects selected for funding.

Read more


New faculty: Lisa Monteggia

Nov. 12, 2018—Lisa Monteggia is professor of pharmacology and Barlow Family Director of the Vanderbilt Brain Institute.

Read more


Three VU doctoral students receive 2018 Gilliam Fellowships for Advanced Study

Aug. 1, 2018—The Howard Hughes Medical Institute has awarded 2018 Gilliam Fellowships for Advanced Study—created to ensure that a diverse and highly trained workforce is prepared to assume leadership roles in the sciences—to three Vanderbilt University doctoral students and their advisers.

Read more


$8.1 million grant funds new center to research highly aggressive form of lung cancer

Jun. 8, 2018—A five-year National Cancer Institute grant will fund an interdisciplinary research center for the study of small cell lung cancer, a highly aggressive, incurable form of the disease.

Read more


Vanderbilt earns top rankings, including a No. 1, for successful minority recruitment in master’s and Ph.D. programs

Dec. 12, 2016—"Diverse: Issues In Higher Education" has ranked Vanderbilt University No. 1 in the country for the number of doctoral degrees awarded to African Americans in the biological and biomedical sciences.

Read more


New faculty: David Sweatt studies how brain chemistry affects learning and memory

Oct. 13, 2016—Homecoming came early this year for Vanderbilt alumnus David Sweatt, who joined the faculty as chair of Pharmacology this summer, 30 years after receiving his Ph.D. from the department he now leads.

Read more


Basic science, extraordinary impact

Oct. 6, 2016—The discoveries that can change the course of human health forever often begin in the tiniest places: in molecules and cells, at the most fundamental intersection of physics, chemistry and biology. Understanding how these cellular and molecular processes work is the focus of basic biomedical research at Vanderbilt.

Read more


New center will examine addiction at molecular level, develop treatments

Aug. 17, 2016—Vanderbilt University researchers from diverse scientific disciplines are joining forces to help crack the stubborn mysteries of addiction through the new Vanderbilt Center for Addiction Research.

Read more


Davies lands Pharmacology teaching award

May. 26, 2016—Sean Davies, Ph.D., associate professor of Pharmacology, was recognized as Pharmacology “Teacher of the Year” during the 25th Annual Joel G. Hardman Student-Invited Pharmacology Forum in Light Hall.

Read more


Sweatt named chair of Department of Pharmacology

Mar. 10, 2016—J. David Sweatt, Ph.D., the Evelyn F. McKnight Endowed Chair of the Department of Neurobiology, director of the Civitan International Research Center, and director of the McKnight Brain Institute at the University of Alabama, Birmingham, has been named chair of Vanderbilt’s Department of Pharmacology.

Read more


Study reveals possible ‘dimmer switch’ drug for Rett syndrome

Mar. 3, 2016—Researchers at Vanderbilt University Medical Center have relieved symptoms in a mouse model of Rett syndrome with a drug-like compound that works like the dimmer switch in an electrical circuit.

Read more


VIEW MORE EVENTS >